Research areas include medicinal chemistry and drug development.
Designing small molecules with specific predicted properties offers great potential in chemistry biology and medicine. Our research objective is to improve the understanding, at the molecular level, of the function of potential drug targets. To do so, we design, synthesize and investigate compounds with specific predicted properties and better drug-like properties, via structure-activity-relationships (SAR) study, that target receptors transporters and enzymes involved in neurodegenerative, cancer and infection disease models. We are also assessing the antioxidant, anticancer and antimicrobial properties of plant extracts toward the identification of potent natural products with better pharmaceutical properties.
Our research interests and activities span many traditional and emerging disciplines of chemistry and biology with noteworthy focuses on the use of computational chemistry, medicinal chemistry and SAR studies complemented with protein chemistry as well as molecular biology to solve biological problems.
- M.Sc., Institut de Pharmacologie, Université de Sherbrooke, 2003
- Ph.D., McGill University, 2008
- Postdoctoral Training, Columbia University, 2008-2013